CONTEXT THERAPEUTICS INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • December 2nd, 2024 • Context Therapeutics Inc. • Pharmaceutical preparations • New York
Context Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:
